Hospital
Vanderbilt University Medical Center
Vanderbilt University Medical Center was paid $8.03M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoVANDERBILT UNIVERSITY MEDICAL CENTER
LEBANON, TN 37087
LEBANON, TN 37087
33aNPI1306889597assigned 06/14/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.03M
24GClaims173,757
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#32 of 71
Median peer was paid$6.96M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,834 | $1.03M | |
| 2019 | 27,042 | $1.07M | |
| 2020 | 17,680 | $819K | |
| 2021 | 29,037 | $1.41M | |
| 2022 | 27,776 | $1.46M | |
| 2023 | 25,331 | $1.43M | |
| 2024incomplete | 14,057 | $812K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 15,365 | 13,611 | $3.03M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 31% | 8,920 | 7,669 | $2.48M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 15,400 | 14,020 | $1.55M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 6,561 | 5,679 | $203K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.4% | 1,922 | 1,762 | $195K |
| G0378 | Hospital observation service, per hour | 1.2% | 536 | 341 | $98K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,003 | 4,300 | $52K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 639 | 584 | $33K |
| 59025 | Fetal non-stress test | <1% | 481 | 267 | $30K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 470 | 427 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,429 | 22,735 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 730 | 675 | $27K |
73 more codes
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 26 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 601 | $24K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,111 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,818 | $23K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,967 | $21K |
| 80053 | Comprehensive metabolic panel | <1% | 9,558 | $19K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 449 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,453 | $16K |
| 84484 | <1% | 3,707 | $10K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 152 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,194 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 256 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,365 | $6K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 89 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 392 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 704 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 176 | $5K |
| 87430 | <1% | 1,186 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 18 | $4K |
| 71250 | <1% | 87 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 79 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,075 | $2K |
| 81025 | <1% | 1,916 | $2K | |
| 80061 | Lipid panel | <1% | 277 | $2K |
| 81001 | <1% | 9,594 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 74 | $2K |
| 83690 | <1% | 3,405 | $1K | |
| 85730 | <1% | 1,144 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 943 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 17,603 | $940.53 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 803 | $800.70 |
| 85610 | <1% | 1,452 | $759.98 | |
| 87420 | <1% | 37 | $319.52 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 456 | $284.92 |
| 81003 | <1% | 1,011 | $273.88 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $246.02 |
| 83735 | <1% | 226 | $242.66 | |
| 80076 | <1% | 11,759 | $229.94 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $172.07 |
| 85379 | <1% | 12 | $162.12 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 18 | $147.36 |
| 83880 | <1% | 21 | $135.72 | |
| 82607 | <1% | 14 | $125.28 | |
| 85027 | <1% | 587 | $109.77 | |
| 82150 | <1% | 58 | $106.76 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15 | $84.47 |
| 83605 | <1% | 50 | $62.31 | |
| 94760 | <1% | 12 | $39.15 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $25.06 |
| 87186 | <1% | 12 | $17.82 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 28 | $13.80 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 12 | $5.18 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 20 | $0.02 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 1,209 | $0.00 |
| 84702 | 0% | 153 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 206 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 83 | $0.00 |
| 87631 | 0% | 229 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 12 | $0.00 |
| 86900 | 0% | 12 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,673 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 287 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 41 | $0.00 |
| J3490 | Unclassified drugs | 0% | 53 | $0.00 |
| A9270 | Non-covered item or service | 0% | 12 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 50 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 40 | $0.00 |
| 82077 | 0% | 61 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 28 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 33 | $0.00 |
| L8699 | Prosthetic implant, not otherwise specified | 0% | 26 | $0.00 |
| 87081 | 0% | 15 | $0.00 | |
| 86901 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, CECELIA (CFO AND TREASURER)
| Provider | Location | Paid |
|---|---|---|
| Clarksville Health System, LLC | Clarksville, TN | $33.01M |
| Vanderbilt Health Clinicians, LLC | Nashville, TN | $8K |
| Vanderbilt University Medical Center | Lebanon, TN | $377.69 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.